FDC Limited, established in 1936, is a vertically integrated
global pharmaceutical company with 7,000+ employees, in-house R&D and
annual revenues of USD 249Million (FY25). Ranked among India’s Top 25 pharma
players, FDC pioneered Oral Rehydration Salts & Ophthalmic therapies, with
leading brands like Electral (India’s No.1 ORS brand), Zifi, & Enerzal.
With 2 USFDA-approved plants and export to 50+ countries, we offer a broad
portfolio across formulations, APIs, and OTC. At CPHI, we welcome partnerships,
in-licensing, out-licensing, CDMO/CMO for both API and Finished Dosage
Formulation.